Hinge Health, Inc.
corporate_fare Company Profile
Hinge Health, Inc. (NYSE:HNGE) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 27 items for HNGE at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-03, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 6 rated 8 or above. Recent SEC coverage for HNGE spans 8-K, 144, 4, 144/A.
Recent high-impact activity:
- Hinge Health President Steps Down to Board as Q3 Revenue Jumps 52%
- Hinge Health Beats Q3 With 52% Revenue Growth, Raises 2026 Guidance; President Moves to Board
- Hinge Health Beats With 52% Revenue Growth, Raises Full-Year Guidance
- Insight Venture Partners Files to Sell $78.7M of Hinge Health — Largest 144 in 90 Days
- 10% Holder Insight Venture Partners Files to Sell $64.5M of Hinge Health
Financial Snapshot
Short Interest & Short Volume
3.60 days to coverFINRA reported short interest of 6,309,855 shares in HNGE as of the October 15, 2026 settlement, a 0.3% decrease from the prior period — about 3.6 days to cover at its recent average daily volume. On November 3, 2026, 43.9% of HNGE volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.